(Q84696065)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20692986%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

In vitro studies of the toxicity of nucleoside analogues used in the treatment of HIV infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20692986%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

O. P. Flint

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692986

18 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20692986

18 June 2024

publication date

1 August 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20692986%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

9 February 2020

https://api.elsevier.com/content/article/PII:0887233394900426?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

https://api.elsevier.com/content/article/PII:0887233394900426?httpAccept=text/plain

18 June 2024

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

18 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20692986%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20692986%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20692986%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

677-683

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20692986%20AND%20SRC:MED&resulttype=core&format=json

Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy

9 February 2020

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Biogenesis of mitochondria

18 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients

18 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC.

18 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

A model for fast axonal transport.

18 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Azidothymidine-induced depression of murine hemopoietic progenitor cells

18 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

In vitro toxicity and metabolism of 2',3'-dideoxycytidine, an inhibitor of human immunodeficiency virus infectivity

18 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity

18 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Phase I study of 2′-3′-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine

18 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Antiretroviral therapy: reverse transcriptase inhibition

18 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial

18 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

3'-Azido-3'-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells

18 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Mitochondrial myopathy caused by long-term zidovudine therapy

18 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC).

18 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection

18 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy

18 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Nature and incidence of peripheral nerve syndromes in HIV infection

18 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Comparison of dideoxynucleoside drugs (DDI and zidovudine) and induction of hematopoietic toxicity using normal human bone marrow cells in vitro

18 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells

18 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Zidovudine-associated myopathy

18 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS)

18 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Anti-HIV drugs: comparative toxicities in murine fetal liver and bone marrow erythroid progenitor cells

18 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

In vivo and in vitro effects of the azidothymidine analog dideoxyinosine on the exocrine pancreas of the rat

18 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Thiol reduction of 3'-azidothymidine to 3'-aminothymidine: kinetics and biomedical implications

18 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

3'-azido-3'-deoxythymidine (AZT) monophosphate: an inhibitor of exonucleolytic repair of AZT-terminated DNA

18 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Zidovudine-associated myopathy

18 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Cardiomyopathy Associated with Antiretroviral Therapy in Patients with HIV Infection: A Report of Six Cases

18 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine

18 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

In vitro bone marrow toxicity of nucleoside analogs against human immunodeficiency virus

18 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Inhibition of bone marrow myelopoiesis and erythropoiesis in vitro by anti-retroviral nucleoside derivatives

18 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

18 June 2024

Antiviral agents

40

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

The pc12 cell as a model for studies of the mechanism of induction of peripheral neuropathy by anti-HIV-1 dideoxynucleoside analogs

18 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine

18 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial

18 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model

18 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria

18 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Specificity of heme for hemopoietic recovery from AZT toxicity

18 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Experimental studies of the hematologic and immune system toxicity of nucleoside derivatives used against HIV infection

18 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Overview of the preclinical development of an antiretroviral drug, 2',3'-dideoxyinosine

18 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Zidovudine and bone marrow

18 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Azidothymidine inhibits mitogen stimulated growth and DNA-repair in human peripheral lymphocytes

18 June 2024

55

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

New antiretroviral agents in the clinic.

18 June 2024

56

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Nucleoside Analogues as Chemotherapeutic Agents: A Review

18 June 2024

58

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies

18 June 2024

60

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

18 June 2024

63

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Hematological effects of 2',3'-dideoxycytidine in rabbits

18 June 2024

64

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Overview of phase I trials of 2',3'-dideoxyinosine (ddI) conducted on adult patients

18 June 2024

65

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Studies on the inhibition of mitochondrial DNA replication by 3'-azido-3'-deoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replication

18 June 2024

67

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?

18 June 2024

68

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Nucleoside analogs: similarities and differences

18 June 2024

69

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Clinical pharmacokinetics of 3'-azido-3'-deoxythymidine (zidovudine) and catabolites with formation of a toxic catabolite, 3'-amino-3'-deoxythymidine

18 June 2024

71

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Hematologic toxicity of AZT and ddC administered as single agents and in combination to rats and mice

18 June 2024

72

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Phase I study of 2',3'-dideoxyinosine: experience with 19 patients at New York University Medical Center

18 June 2024

73

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study

18 June 2024

74

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Participation of the mitochondrial genome in the differentiation of neuroblastoma cells

18 June 2024

75

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

18 June 2024

77

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complex

18 June 2024

78

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90042-6

18 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20692986%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference